"Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer

Published: Sept. 28, 2009, 11:24 a.m.

b'BARCELONA, SPAIN\\u2014Adding cetuximab to gemcitabine/oxaliplatin (GEMOX) chemotherapy controlled disease among two thirds of patients with advanced biliary cancer in a trial reported at the World Congress on Gastrointestinal Cancer. \\xc9veline Boucher from the Centre Eugene Marquis, in Rennes, France, presented preliminary findings from a phase II open-label study among 101 patients who had not already received palliative treatment for their advanced biliary cancers, and had WHO performance status 0-1.\\nShe discussed her team\\u2019s findings with Peter Goodwin.'